These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 1530411)

  • 1. [Thrombolytic treatment during the acute phase of myocardial infarction. An important reduction of early and secondary mortality].
    Charbonnier B
    Arch Mal Coeur Vaiss; 1992 May; 85(5 Suppl):697-705. PubMed ID: 1530411
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [t-PA in thrombolytic therapy of acute myocardial infarct].
    Rutsch W; Schmutzler H
    Herz; 1994 Dec; 19(6):336-52. PubMed ID: 7843690
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effects of thrombolytic treatments on the mortality of myocardial infarction. Characteristics of large-scale trials, main results].
    Slama M; Cohen-Solal A; Spriet A
    Arch Mal Coeur Vaiss; 1989 Oct; 82 Spec No 3():27-33. PubMed ID: 2512885
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Myocardial infarction treated within 4 hrs: comparison of the cost-benefit ratio of 3 thrombolytic treatments: APSAC, rt-PA and streptokinase in 270 patients].
    Machecourt J; Cassagnes J; Bassand JP; Dumoulin J; Calop J; Foroni L; Terrisse MP; Hénon T; Petit L; Denis B
    Arch Mal Coeur Vaiss; 1993 Feb; 86(2):209-17. PubMed ID: 8363422
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Thrombolytic treatment of myocardial infarction. Data on the limitation of infarction size and left ventricular function].
    Barraud P; Marcaggi X; Boueyre M; Schandrin C; Regeard E; Maublant J; Lusson JR; Cassagnes J
    Arch Mal Coeur Vaiss; 1992 May; 85(5 Suppl):689-95. PubMed ID: 1530410
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Elements of choice of thrombolytic agents in myocardial infarction].
    Samama M; Brochet E; Valère PE
    Arch Mal Coeur Vaiss; 1992 May; 85(5 Suppl):721-7. PubMed ID: 1530414
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coronary thrombolysis with clot-selective plasminogen activators.
    Collen D; Bounameaux H
    Herz; 1986 Feb; 11(1):9-15. PubMed ID: 3082731
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Platelet activation in the early phases of acute myocardial infarction].
    Salvioni A; Giraldi F; Assanelli E; Lauri G; Grazi M; Pardea S; Marenzi G
    Cardiologia; 1998 Aug; 43(8):825-32. PubMed ID: 9808873
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Time to treatment with thrombolytic therapy: determinants and effect on short-term nonfatal outcomes of acute myocardial infarction. Canadian GUSTO Investigators. Global Utilization of Streptokinase and + PA for Occluded Coronary Arteries.
    Cox JL; Lee E; Langer A; Armstrong PW; Naylor CD
    CMAJ; 1997 Feb; 156(4):497-505. PubMed ID: 9054819
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Prehospital thrombolytic therapy of acute myocardial infarct].
    Tebbe U; Carlsson J
    Herz; 1994 Dec; 19(6):303-13. PubMed ID: 7843687
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Thrombolytic therapy in acute myocardial infarct].
    Verstraete M
    Recenti Prog Med; 1990 Apr; 81(4):287-98. PubMed ID: 2198644
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thrombolytic therapy for acute myocardial infarction: a brief review.
    Kennedy JW
    Heart Lung; 1987 Nov; 16(6 Pt 2):740-5. PubMed ID: 3679868
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Arterial permeability, objective of thrombolytic therapy].
    Bassand JP; Schiele F; Bernard Y; Anguenot T
    Arch Mal Coeur Vaiss; 1992 May; 85(5 Suppl):677-87. PubMed ID: 1530409
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New developments in thrombolytic therapy.
    Collen D; Gold HK
    Verh K Acad Geneeskd Belg; 1989; 51(3):191-228; discussion 229. PubMed ID: 2686261
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Accelerated infusion of streptokinase in acute myocardial infarction results in better TIMI flow grade in infarct-related artery.
    Dwivedi SK; Saran RK; Narain VS; Bansal S; Gupta R; Puri VK
    Indian Heart J; 2000; 52(1):40-4. PubMed ID: 10820932
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Thrombolytic therapy of myocardial infarction: practical management].
    Bonnet JL; Bory M
    Arch Mal Coeur Vaiss; 1992 May; 85(5 Suppl):707-12. PubMed ID: 1530412
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overview: rationale of thrombolysis in treating acute myocardial infarction.
    Rapaport E
    Heart Lung; 1991 Sep; 20(5 Pt 2):538-41. PubMed ID: 1894538
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [New thrombolytic agents in myocardial infarction].
    Charbonnier B; Lang M; Brochier M
    Arch Mal Coeur Vaiss; 1987 Nov; 80(12):1785-91. PubMed ID: 3128222
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [PTCA in acute myocardial infarct: primary, immediate, delayed or elective?].
    Rutsch W
    Herz; 1992 Feb; 17(1):50-63. PubMed ID: 1541450
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Are ECG criteria for indications for thrombolysis in acute myocardial infarct defined too narrowly?].
    Weiss P; Sarasin C; Ritz R; Pfisterer M
    Schweiz Med Wochenschr; 1991 Dec; 121(49):1829-32. PubMed ID: 1754866
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.